GlassScriptPhysician profile
Jourdan M Cancienne
NPI 1821433210
$224,265.69
in general payments reported to CMS, 2019-2025
23 companies · $76K in 2025
The $76K reported for 2025 was more than what 96% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $4,366 · 2021: $12K · 2022: $28K · 2023: $24K · 2024: $34K · 2025: $76K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $76K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Travel and Lodging: $14K · Food and Beverage: $7,170 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $75,900.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,154.38 |
| Travel and Lodging | $13,993.27 |
| Food and Beverage | $7,170.18 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $146,251.89 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System, Healicoil |
| Arthrex, INC. | $38,753.64 | 2019-2023 | Arthrex |
| Stryker Corporation | $11,922.45 | 2019-2025 | Blueprint Patient Specific Instrumentation, Pangea, Actishield |
| Medwest Associates | $8,672.51 | 2022-2023 | |
| Alon Medical Technology | $8,641.74 | 2019-2021 | |
| Synthes Gmbh | $4,781.21 | 2023-2025 | |
| Rti Surgical, INC | $2,500.00 | 2022 | |
| Medical Device Business Services, INC. | $1,518.48 | 2019 | |
| Depuy Synthes Sales INC. | $308.80 | 2019-2025 | Monovisc |
| Bioventus LLC | $178.43 | 2019 | |
| Sanara Medtech INC. | $152.09 | 2021 | |
| Lightbody Medical Technologies INC | $148.16 | 2025 | |
| Fx Shoulder Solutions, INC | $93.33 | 2024 | |
| Anika Therapeutics, INC. | $78.40 | 2025 | Integrity Implant |
| Orthofix Medical, INC. | $54.79 | 2023-2024 | Physio-Stim, Cervical-Stim |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Orthoscience | $41.52 | 2022 | |
| Ethicon US, LLC | $37.81 | 2022 | |
| Davol INC. | $28.64 | 2024 | |
| Acumed LLC | $27.95 | 2025 | Acumed |
| Oak Med, INC. | $24.77 | 2025 | |
| Heraeus Medical, LLC. | $18.07 | 2022 | |
| Vericel Corporation | $15.91 | 2019 | |
| Abbott Laboratories | $15.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jourdan Cancienne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.